Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence

Abstract

Viral DNA replication is generally dependent upon circumventing host cell cycle control to force S phase entry in an otherwise quiescent cell. Here we describe novel attributes of the cyclin encoded by Human Herpesvirus 8 (K cyclin) that enable it to subvert the quiescent state. K cyclin is most similar to the mammalian D-type cyclins in primary sequence but displays properties more akin to those of cyclin E. K cyclin (like cyclin E) can autonomously couple with its cognate cdk subunit and localize to the nucleus. D-type cyclins require mitogen stimulated accessory factors (such as p21Cip1 and p27Kip1) to facilitate both of these processes. A striking difference between K cyclin and mammalian cyclins is that K cyclin binding to cdk6 can substantially activate the catalytic activity of the complex without the requirement for cyclin H/cdk7 phosphorylation of the cdk T-loop; this phosphorylation is obligatory for endogenous cyclin/cdk activity. However, K cyclin/cdk6 complexes are not totally immune from cell cycle control since CAK phosphorylation is necessary for complete activation. Thus, CAK phosphorylated K cyclin/cdk6 targets multiple sites in the retinoblastoma protein (pRb) whereas the unphosphorylated complex targets a single site. The restricted substrate specificity of the non-CAK phosphorylated K cyclin/cdk6 complex is insufficient to enable K cyclin-mediated S phase entry. Thus, the viral K cyclin is reliant upon endogenous CAK activity to subvert the quiescent state.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Arooz T, Yam CH, Siu WY, Lau A, Li KK, Poon RY . 2000 Biochemistry 39: 9494–9501

  • Bates S, Bonetta L, MacAllan D, Parry D, Holder A, Dickson C, Peters G . 1994 Oncogene 91: 71–79

  • Bridger JM, Kill IK, O Farrell M, Hutchinson CJ . 1993 J. Cell Sci. 104: 297–306

  • Brown AJ, Jones T, Shuttleworth J . 1994 Mol. Biol. Cell 5: 921–932

  • Brown NR, Noble ME, Endicott JA, Johnson LN . 1999 Nature Cell Biol. 1: 438–443

  • Card GL, Knowles P, Laman H, Jones N, McDonald NQ . 2000 EMBO J. 19: 2877–2888

  • Cheng M, Sexl V, Sherr CJ, Roussel MF . 1998 Proc. Natl. Acad. Sci. USA 95: 1091–1096

  • Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ . 1999 EMBO J. 18: 1571–1583

  • Coats S, Flanagan WM, Nourse J, Roberts JM . 1996 Science 272: 877–880

  • Connell-Crowley L, Elledge SJ, Harper JW . 1998 Current Biol. 8: 65–68

  • De Bondt HL, Rosenblatt J, Jancarik J, Jones HD, Morgan DO, Kim SH . 1993 Nature 363: 592–602

  • Diehl JA, Sherr CJ . 1997 Mol. Cell. Biol. 17: 7362–7374

  • Dyson N . 1998 Genes Dev. 12: 2245–2262

  • Ellis M, Chew YP, Fallis L, Freddersdorf S, Boshoff C, Weiss RA, Lu X, Mittnacht S . 1999 EMBO J. 18: 644–653

  • Godden-Kent D, Talbot SJ, Boschoff C, Chang Y, Moore P, Weiss RA, Mittnacht S . 1997 J. Virol. 71: 4193–4198

  • Jeffrey PD, Russo AA, Polyak K, Gibbs E, Hurwitz J, Massague J, Pavletich NP . 1995 Nature 376: 313–320

  • Jung JU, Stager M, Desrosiers RC . 1994 Mol. Cell. Biol. 14: 7235–7244

  • Kato JY, Matsuoka M, Strom DK, Sherr CJ . 1994 Mol. Cell. Biol. 14: 2713–2721

  • Kelly BL, Wolfe KG, Roberts JM . 1998 Proc. Natl. Acad. Sci. USA. 95: 2535–2540

  • Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM . 1992 Science 257: 1689–1694

  • LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E . 1997 Genes. Dev. 11: 847–862

  • Lee A, Farnham PJ . 2000 Oncogene 19: 2257–2268

  • Leng X, Connell-Crowley L, Goodrich D, Harper JW . 1997 Current Biol. 7: 709–712

  • Li M, Lee H, Yoon DW, Albrecht JC, Fleckenstein B, Neipel F, Jung JU . 1997 J. Virol. 71: 1984–1991

  • Lukas J, Bartkova J, Bartek J . 1996 Mol. Cell. Biol. 16: 6917–6925

  • Lukas J, Herzinger T, Hansen K, Moroni MC, Resnitzky D, Helin K, Reed SI, Bartek J . 1997 Genes. Dev. 11: 1479–1492

  • Lundberg AS, Weinberg RA . 1998 Mol. Cell. Biol. 18: 753–761

  • Mann DJ, Jones NC . 1996 Current Biology 6: 474–483

  • Mann DJ, Higgins T, Jones NC, Rozengurt E . 1997 Oncogene 14: 1759–1766

  • Mann DJ, Child ES, Swanton C, Laman H, Jones N . 1999 EMBO J. 18: 654–663

  • Matsuoka M, Kato J, Fisher RP, Morgan DO, Sherr CJ . 1994 Mol. Cell. Biol. 14: 7265–7275

  • Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF, Sherr CJ . 1992 Cell 71: 323–334

  • Meyerson M, Harlow E . 1994 Mol. Cell. Biol. 14: 2077–2086

  • Moore JD, Yang J, Truant R, Kornbluth S . 1999 J. Cell. Biol. 144: 213–224

  • Muller D, Bouchard C, Rudolph B, Steiner P, Stuckmann I, Saffrich R, Asoroe W, Huttner W, Eilers M . 1997 Oncogene 15: 2561–2576

  • Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M . 1995 Mol. Cell. Biol. 15: 2612–2624

  • Pavletich NP . 1999 J. Mol. Biol. 287: 821–828

  • Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempest P, Massague J . 1994 Cell 78: 59–66

  • Poon RY, Yamashita K, Adamczewski JP, Hunt T, Shuttleworth J . 1993 EMBO J. 12: 3123–3132

  • Quelle DE, Ashmun RA, Shurtleff SA, Kato J, Bar-Sagi D, Roussel MF, Sherr CJ . 1993 Genes. Dev. 7: 1559–1571

  • Resnitzky D, Gossen M, Bujard H, Reed SI . 1994 Mol. Cell. Biol. 14: 1669–1679

  • Resnitzky D, Reed SI . 1995 Mol. Cell. Biol. 15: 3463–3469

  • Russo AA, Jeffrey PD, Pavletich NP . 1996 Nature Str. Biol. 3: 696–700

  • Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE . 1997 Genes. Dev. 11: 1464–1478

  • Sherr CJ . 1993 Cell 73: 1059–1065

  • Soos TJ, Kiyokawa H, Yan JS, Rubin MS, Giordano A, DeBlasio A, Bottega S, Wong B, Mendelsohn J, Koff A . 1996 Cell. Growth Differ. 7: 135–146

  • Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N . 1997 Nature 390: 184–187

  • Tassan JP, Schultz SJ, Bartek J, Nigg EA . 1994 J. Cell. Biol. 127: 467–478

  • Toyoshima H, Hunter T . 1994 Cell 78: 67–74

  • Vlach J, Hennecke S, Amati B . 1997 EMBO J. 16: 5334–5344

  • Yang J, Kornbluth S . 1999 Trends Cell. Biol. 9: 207–210

Download references

Acknowledgements

We thank D Bentley, E Harlow, M Meyerson, D Morgan, G Peters and C Sherr for generously supplying reagents and N Jones, G Peters and H Laman for critical reading of the manuscript. We also thank D Davies for FACS analysis and I Kill for help with the fluorescence microscopy. This work was supported by the Cancer Research Campaign (DJ Mann).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Child, E., Mann, D. Novel properties of the cyclin encoded by Human Herpesvirus 8 that facilitate exit from quiescence. Oncogene 20, 3311–3322 (2001). https://doi.org/10.1038/sj.onc.1204447

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204447

Keywords

This article is cited by

Search

Quick links